Stockreport

Crossbow raises $77M for new cancer immunotherapies [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Crossbow Therapeutics, a cancer drugmaker developing next-generation T cell engagers, announced Wednesday it raised $77 million in a Series B round to continue studying [Read more]